Fig. 1

Study Framework. This study first employed network pharmacology and bioinformatics to identify the core ingredients, hub targets, and signaling pathways associated with QJZG in the treatment of SS. Subsequently, molecular docking, transcriptomic sequencing, and in vitro cell experiments were conducted to validate the findings from the network pharmacology analysis.